Paragon Biosciences makes investments and grows leading companies in the biotechnology industry led by Jeff Aronin. Paragon Biosciences focuses on the patient first, then the science, and consequently on building the company that addresses these concerns. Their goal is to discover and provide treatments for more than 6000 diseases that currently do not have treatments by investing in and therefore building biotechnology companies that do this. The result is longer, healthier, and happier lives for patients. Some companies that Paragon biosciences have invested in include Castle Creek pharmaceuticals, harmony biosciences, decade, and precision BP (https://gazetteday.com/2018/02/jeff-aronin/). Paragon biosciences focuses on the therapeutic areas of central nervous system disorder, orphaned dermatology, broad dermatology, and other high medical need. Paragon biosciences contribute to enhancing the human experience.
The chairman and CEO of Paragon biosciences since 2010 is Jeff Aronin. Jeff Aronin was previously the president and chief executive officer of ovation pharmaceuticals Inc. which he founded in the year 2000. Ovation Pharmaceuticals got acquired by Lundbeck Inc. in 2009 Jeff Aronin founded Lundbeck Inc. in the year 2000. He is a special advisor at Merrick Ventures, LLC and is the founder of MATTER. Jeff Aronin has extensive experience and knowledge of growing biopharmaceutical companies. He has special abilities and business development, finance, and brand marketing. He has led numerous healthcare companies to success. He has worked with American Health Products Corporation, Carter-Wallace, and MedCare. He is on the board of the epilepsy foundation and the Young President Organization. Jeff Aronin has worked with and served for many successful biotechnology companies and other businesses, and he has received honors and recognition for his excellence in business. He received Ernst and Young’s Entrepreneur of the Year Award and got inducted into the Illinois Entrepreneur Hall of Fame. Jeff Aronin obtained his bachelor’s degree at Northern Illinois University. He got his MBA at DePaul University.